Results 101 to 110 of about 5,242 (246)

Searching for non-English literature may be unnecessary for German HTA Reports [version 3; peer review: 2 approved, 2 approved with reservations, 1 not approved]

F1000Research
Background Health technology assessment (HTA) reports are based on comprehensive information retrieval. Current standards discourage the use of search restrictions, such as publication date and language.
Stefan Sauerland, Wiebke Sieben, Lisa Schell, Sandra Molnar, Sibylle Sturtz, Elke Hausner   +5 more
doaj   +1 more source

The value of health care – a matter of discussion in Germany

BMC Health Services Research, 2007
Background Interest in assessing the value of health-care services in Germany has considerably increased since the foundation of the Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG (Institute for Quality and Efficiency in Health ...
Ackermann Moritz, Porzsolt Franz, Amelung Volker   +2 more
doaj   +1 more source

Politik-Check Pharmastandort Deutschland: Potenziale erkennen - Chancen nutzen [PDF]

, 2008
Zukünftig wird das wirtschaftliche Wachstum vor allem durch die kapital- und wissensintensiven Industrien getragen. Die forschungsintensive Pharmabranche gehört dabei zu den zentralen Zukunftsbranchen.
Bräuninger, Michael, Fitzner, Volker, Kriedel, Norbert, Kusnierz-Glaz, Claus, Schulze, Sven, Straubhaar, Thomas, Teichmann, Georg A., Twelsiek, Oliver, Vöpel, Henning   +8 more
core  

Searching for non-English literature may be unnecessary for German HTA Reports [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved]

F1000Research
Background Health technology assessment (HTA) reports are based on comprehensive information retrieval. Current standards discourage the use of search restrictions, such as publication date and language.
Stefan Sauerland, Wiebke Sieben, Lisa Schell, Sandra Molnar, Sibylle Sturtz, Elke Hausner   +5 more
doaj   +1 more source

Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information

Journal of European CME, 2021
Natalie McGauran, Beate Wieseler
doaj   +1 more source

Umsetzung des AMNOG in die Versorgungspraxis [PDF]

, 2016
[Hintergrund] Im Rahmen des Arzneimittelmarktneuordnungsgesetzes (AMNOG) wurde die Preisbildung für patentgeschützte Arzneimittel und damit die Erstattung durch die Gesetzliche Krankenversicherung (GKV) neu geregelt.
Bauer, Cosima, May, Uwe, Walendzik, Anke, Wasem, Jürgen, Weegen, Lennart   +4 more
core  

'Aus oekonomischer Sicht ...' [PDF]

Economists, and notably health economists, very often add to their policy recommendations the formula ,from an economic point of view'. The contribution starts by exploring what the message of this clause to non-economists might be. The vagueness that it
Weyma Luebbe
core  

Patienten auf dem Weg zur Macht? : Ergebnisse rot-grüner Gesundheitspolitik [PDF]

, 2006
Die erstmalige Übertragung der Regierungsverantwortung im Jahr 1998 an eine Koalition aus SPD und Bündnis90/Die Grünen auf der Bundesebene hat Erwartungen geweckt, dass sich die gesundheitspolitische Ausrichtung stärker an den Interessen von Patientinnen
Mosebach, Kai
core  

A Pharmaceutical Innovation – Is it Worth the Money? Whose Money? [PDF]

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance.
Michele Sennhauser, Peter Zweifel
core  

Patients' preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study

Patient Preference and Adherence, 2018
Vera Vennedey,1 Sonja HM Derman,2 Mickaël Hiligsmann,3 Daniele Civello,1 Anja Schwalm,4 Astrid Seidl,4 Fülöp Scheibler,5 Stephanie Stock,1 Michael J Noack,2 Marion Danner1,5 1Institute for Health Economics and Clinical Epidemiology ...
Vennedey V, Derman SHM, Hiligsmann M, Civello D, Schwalm A, Seidl A, Scheibler F, Stock S, Noack MJ, Danner M   +9 more
doaj